Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies-Reference-Cited by-同舟云学术

Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies

Published:2018-02 Issue:1 Volume:40 Page:115-119
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Suh Hyeon Jeong,Kim Inho,Cho Joo-Youn,Park Sang-In,Yoon Seo Hyun,Hwang Joo-Hee,Bae Ji Yun,Lee Jeong-Ok,Koh Youngil,Song Kyoung-Ho,Choe Pyoeng Gyun,Yu Kyung-Sang,Kim Eu Suk,Kim Hong Bin,Bang Soo-Mee,Kim Nam Joong,Song Sang Hoon,Park Wan Beom,Oh Myoung-don

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia;Cornely;N Engl J Med.,2007

2. Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece;Athanasakis;J Med Econ.,2013

3. An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States;Sung;J Med Econ.,2015

4. Real-life assessment of the safety and effectiveness of the new tablet and intravenous formulations of posaconazole in the prophylaxis of invasive fungal infections: analysis of 343 courses;Tverdek;Antimicrob Agents Chemother.,2017

5. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults;Courtney;Br J Clin Pharmacol.,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for posaconazole therapeutic drug monitoring and their clinical benefits;European Journal of Clinical Pharmacology;2024-09-09

2. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

3. Effects of Triazole Antifungal Agents on the Plasma Concentration and Dosage of Cyclosporin in Patients with Aplastic Anaemia;Journal of Clinical Pharmacy and Therapeutics;2024-02-27

4. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO);Journal of Antimicrobial Chemotherapy;2023-06-13

5. Chemical and biological aspects of posaconazole as a classic antifungal agent with non-classical properties: highlighting a tetrahydrofuran-based drug toward generation of new drugs;Medicinal Chemistry Research;2022-05-19